Entering text into the input field will update the search result below

Madrigal Pharmaceuticals EPS in-line

  • Madrigal Pharmaceuticals (NASDAQ:MDGL): Q3 GAAP EPS of -$1.39 in-line.
  • Cash, cash equivalents and marketable securities of $453.6M
  • Press Release

Recommended For You

More Trending News

About MDGL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MDGL--
Madrigal Pharmaceuticals, Inc.